NCT05233449

Brief Summary

The Nociception Level (NoL) is an index obtained via a non-invasive monitor, that is currently used to assess nociception in anesthetized adults. The NoL index varies from 0 to 100. It increases in response to nociceptive stimuli. The objective of this study was to investigate if the NoL index also indicates the level of nociception in anesthetized children. In children anesthetized according to standard practice, before surgical incision, three 5-seconds stimulations will be performed with different intensities (10, 30 and 60 milliamps). The order of the stimulations intensities will be randomized. The hypothesis of study is that the intensity of stimulation will influence the magnitude of NoL-index increase in response to the stimulation.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Mar 2022

Shorter than P25 for not_applicable

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 31, 2022

Completed
10 days until next milestone

First Posted

Study publicly available on registry

February 10, 2022

Completed
22 days until next milestone

Study Start

First participant enrolled

March 4, 2022

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 17, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 17, 2022

Completed
Last Updated

December 26, 2025

Status Verified

December 1, 2025

Enrollment Period

2 months

First QC Date

January 31, 2022

Last Update Submit

December 18, 2025

Conditions

Keywords

General anesthesiaNociceptionMonitoringNociception levelNoL

Outcome Measures

Primary Outcomes (1)

  • NoL variation = [(Maximal NoL value in the 5 minutes following the stimulation) - (NoL before stimulation)] / [NoL before stimulation]

    NoL variation = \[(Maximal NoL value in the 5 minutes following the stimulation) - (NoL before stimulation)\] / \[NoL before stimulation\]

    5 minutes after stimulation

Secondary Outcomes (2)

  • Systolic Blood Pressure (SBP) variation

    5 minutes after stimulation

  • Analgesia Nociception Index (ANI) variation

    5 minutes after stimulation

Study Arms (1)

Children anesthetized

EXPERIMENTAL

Inhalatory general anesthesia with sevoflurane 0.9 Minimal Alveolar Concentration and alfentanil 10 µg/kg

Device: NoL monitorProcedure: Stimulation

Interventions

NoL monitor : non invasive, adhesive digital device

Children anesthetized
StimulationPROCEDURE

Stimulation : 100 Hertz, 5 seconds, 10-30-60 milliamps, inner forearm

Children anesthetized

Eligibility Criteria

Age5 Years - 12 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Age 5-12 years
  • Elective surgery under general anesthesia
  • Written informed consent

You may not qualify if:

  • Cardiac surgery
  • Opioid intake \< 24 hours before surgery
  • Cardiac arrhythmia
  • Pace maker
  • Pheochromocytoma
  • Anti-arrhythmic medication
  • Anticholinergic medication
  • Raynaud syndrome
  • Digital anomaly (malformative, traumatic)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Hopital Roger Salengro, CHU Lille

Lille, France

Location

Hu Est Parisien Site Trousseau Aphp

Paris, France

Location

Related Publications (1)

  • Chemam S, Cailliau E, Bert D, Tavernier B, Constant I, Sabourdin N. Nociception level response to calibrated stimulations in children: First assessment of the nociception level index in pediatric anesthesia. Anaesth Crit Care Pain Med. 2023 Jun;42(3):101207. doi: 10.1016/j.accpm.2023.101207. Epub 2023 Mar 1.

Study Officials

  • Nada Sabourdin, MD

    University Hospital, Lille

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Model Details: In order to avoid the bias related to the order of the stimuli, the order of application of the stimuli will be randomized according to a Latin square of order 3.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 31, 2022

First Posted

February 10, 2022

Study Start

March 4, 2022

Primary Completion

May 17, 2022

Study Completion

May 17, 2022

Last Updated

December 26, 2025

Record last verified: 2025-12

Locations